Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors (vol 4, 5, 2017)FRONTIERS IN MEDICINEIF32017-04-120OAAI
Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast PrecursorsFRONTIERS IN MEDICINEIF32017-01-2716OAAI
EFFECT OF TNF BLOCKING THERAPY ON OSTEOCLASTS FROM ANKYLOSING SPONDYLITIS PATIENTSANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-010PREAI
RANK EXPRESSION IS REDUCED IN CIRCULATING MONOCYTES FROM ANKYLOSING SPONDYLITIS PATIENTSANNALS OF THE RHEUMATIC DISEASESIF20.62014-03-010PREAI
Rheumatoid Arthritis Bone Fragility Is Associated With Upregulation of IL17 and DKK1 Gene ExpressionCLINICAL REVIEWS IN ALLERGY & IMMUNOLOGYIF11.32013-04-0229PREAI
Low osteocalcin/collagen type I bone gene expression ratio is associated with hip fragility fracturesBONEIF3.62012-12-0128PREAI
RANKL expression in circulating neutrophils is decreased after TNF-blocking therapy in rheumatoid arthritis patientsBONEIF3.62012-05-010PREAI
Apolipoprotein E and undercaboxylated osteocalcin are associated with bone fragility but not with bone mineral density in osteoarthritis patientsBONEIF3.62012-05-010PREAI
Rheumatoid arthritis bone fragility is associated with increased DKK1 expression and disturbances in the bone turnover regulating genesBONEIF3.62012-05-010PREAI
TNF promoter-308 G>A and LTA 252 A>G polymorphisms in Portuguese patients with systemic lupus erythematosusRHEUMATOLOGY INTERNATIONALIF2.92011-05-0513PREAI
Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healingBONEIF3.62011-05-010OAAI
Lymphotoxin-α 252 A>G Polymorphism: A Link Between Disease Susceptibility and Dyslipidemia in Rheumatoid Arthritis?JOURNAL OF RHEUMATOLOGYIF3.42011-04-0117OAAI
SPONDYLOARTHRITIS AND RHEUMATOID ARTHRITIS: DIFFERENT CLINICAL MANIFESTATIONS, SIMILAR CYTOKINE NETWORKANNALS OF THE RHEUMATIC DISEASESIF20.62011-03-012OAAI
CYTOKINE PROFILE IN SERUM AND SYNOVIAL FLUID OF PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.62010-03-015OAAI
INFLUENCE OF ANTI-TUMOUR NECROSIS FACTOR DRUGS, TOCILIZUMAB AND METHOTREXATE ON OSTEOCLAST DIFFERENTIATIONANNALS OF THE RHEUMATIC DISEASESIF20.62010-03-010OAAI
BONE CELL ACTIVITY INFLUENCES BONE FRAGILITY AND FRACTURE RISKANNALS OF THE RHEUMATIC DISEASESIF20.62010-03-010OAAI
TUMOUR NECROSIS FACTOR ANTAGONISTS AND TOCILIZUMAB HAVE A HIGHER IMPACT ON RHEUMATOID ARTHRITIS OSTEOCLASTOGENIC STIMULI THAN METHOTREXATEANNALS OF THE RHEUMATIC DISEASESIF20.62010-03-010OAAI